Choosing the wrong packaging material can undermine years of formulation work in a matter of months. Packaging material selection errors remain one of the more preventable causes of product recalls, stability failures, and regulatory delays across the pharmaceutical industry.

Why Packaging Material Selection Errors Happen

Many packaging material selection errors trace back to insufficient compatibility testing between the formulation and the container-closure system. Teams under launch timeline pressure sometimes finalize packaging decisions before completing full stability studies, assuming a material that worked for a similar product will perform identically for a new one. This assumption often overlooks subtle formulation differences that can significantly affect material compatibility.

Common Types of Packaging Material Selection Errors

Moisture permeability mismatches represent a frequent error, particularly for hygroscopic APIs packaged in materials with inadequate barrier properties. Light transmission oversights also occur regularly, where photosensitive formulations end up in clear packaging without adequate UV protection. Leachable and extractable interactions form another common category, where packaging components migrate into the formulation and either degrade the API or introduce safety concerns.

Consequences of Getting Packaging Wrong

A packaging material selection error discovered late in development can force a complete redesign, delaying regulatory submission and launch timelines significantly. Errors discovered post-launch carry heavier consequences, potentially triggering recalls, stability failure investigations, and regulatory scrutiny that affects a company’s broader product portfolio credibility.

How to Avoid These Errors

Comprehensive compatibility testing early in development remains the most effective safeguard. This includes accelerated and real-time stability studies using the actual intended packaging, not a substitute material assumed to be equivalent. Cross-functional collaboration between formulation, packaging engineering, and regulatory teams also helps catch potential issues before they become costly late-stage problems.

Regulatory Expectations Around Packaging Selection

Regulatory bodies including the FDA expect documented justification for container-closure system selection, including compatibility and stability data specific to the formulation. Insufficient documentation in this area is a common source of regulatory queries during submission review.

Frequently Asked Questions

What is the most common packaging material selection error?
Insufficient compatibility testing between the formulation and the container-closure system is among the most frequent errors, often stemming from assumptions based on similar past products.

When should packaging compatibility testing begin?
Testing should begin early in formulation development, using the actual intended packaging material, rather than being finalized late in the development timeline.

Contact Our Team

We support pharmaceutical manufacturers in selecting and validating packaging materials suited to their specific formulation requirements.

Contact us today to discuss your packaging compatibility needs.